The tumor suppressor FoxO3a increases its levels of acetylation in mouse embryonic fibroblasts depleted of SIRT6, whereas its induction by epirubicin is attenuated in breast cancer cells overexpressing SIRT6 [65]. This evidence concerns the gene SIRT6 and neoplasm.